Jo Bradwell
Jo Bradwell is a British medical researcher and entrepreneur known for his contributions to the field of clinical immunology and the development of diagnostic tests for multiple myeloma and other plasma cell disorders. He is the founder of The Binding Site, a company specializing in the production of diagnostic assays.
Early Life and Education[edit | edit source]
Jo Bradwell was born in Birmingham, England. He completed his medical degree at the University of Birmingham and later pursued a PhD in immunology.
Career[edit | edit source]
Bradwell began his career as a clinical immunologist at the Queen Elizabeth Hospital Birmingham. His research focused on the development of diagnostic tests for plasma cell disorders, particularly multiple myeloma. In 1983, he founded The Binding Site, which has since become a leading company in the field of immunodiagnostics.
The Binding Site[edit | edit source]
The Binding Site was established to commercialize the diagnostic tests developed by Bradwell and his team. The company is best known for its Freelite® assays, which are used worldwide for the diagnosis and monitoring of multiple myeloma and other related conditions. The Binding Site has grown significantly under Bradwell's leadership and continues to be a major player in the field of diagnostic testing.
Contributions to Medicine[edit | edit source]
Bradwell's work has had a significant impact on the diagnosis and treatment of plasma cell disorders. His development of the Freelite® assay has provided clinicians with a reliable tool for the early detection and monitoring of multiple myeloma, improving patient outcomes.
Awards and Recognition[edit | edit source]
Throughout his career, Jo Bradwell has received numerous awards and honors for his contributions to medical research and diagnostics. He has been recognized by various professional organizations and continues to be an influential figure in the field of clinical immunology.
Personal Life[edit | edit source]
Jo Bradwell resides in Birmingham and remains actively involved in medical research and the operations of The Binding Site.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
